<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dermira, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dermira, Inc.

    Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering important new treatments to the millions of patients living with chronic skin conditions. We are committed to understanding the needs of both patients and physicians and using our insight to identify and develop leading-edge medical dermatology clinical programs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Thomas G. Wiggans
    • FOUNDED
      2010
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    NuVasive, Inc.

    NuVasive, Inc.

    NuVasive is a world leader in minimally invasive, procedurally integrated spine so...

    NuVasive is a world leader in minimally invasiv...

    Filing Type:    PU
    Applied Science Products, Inc.

    Applied Science Products, Inc.

    Applied Science Products operates Advanced Plasma Products, Inc., a science and en...

    Applied Science Products operates Advanced Plas...

    Neurohacker Collective, LLC

    Neurohacker Collective, LLC

    Neurohacker Collective was founded in 2015 with the mission of creating best in cl...

    Neurohacker Collective was founded in 2015 with...

    Amount Raised:    $1,518,491.00
    Fundraising Status:    EC
    Filing Type:    CF
    Progenics Pharmaceuticals Inc.

    Progenics Pharmaceuticals Inc.

    Progenics develops innovative medicines and other technologies to target and treat...

    Progenics develops innovative medicines and oth...

    Filing Type:    PU
    VBI Vaccines, Inc.

    VBI Vaccines, Inc.

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company d...

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercia...

    Filing Type:    PU
    AzurRx BioPharma, Inc.

    AzurRx BioPharma, Inc.

    AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) f...

    AzurRx BioPharma is a development stage biophar...

    Filing Type:    PU
    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals is a specialty pharmaceutical company, committed to address...

    Foamix Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Edesa Biotech, Inc.

    Edesa Biotech, Inc.

    Edesa Biotech Inc. is a clinical-stage biopharmaceutical company founded by expert...

    Edesa Biotech Inc. is a clinical-stage biopharm...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.